Skip to main content

UBS Group AG

Position in PACB — Pacific Biosciences Of California, Inc.

CIK 1610520 ZURICH, V8

Position in PACB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,500,474
-$664,455 QoQ
Shares Held
893,140
-45.5% QoQ
Ownership
0.287%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 222 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 82% Shared 0% None 18%

Common Shares in PACB Over Time

Shares Held

Position Value (USD)

Derivatives in PACB

reported options exposure · as of Mar 31, 2023
CallValue
$8,674,578
CallShares
749,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,686,473,125 across 138 Medical Devices names. PACB ranks #60 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PACB

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,500,474 893,140
2026-03-31 $2,164,929 1,640,099
2025-12-31 $5,930,788 3,171,546
2025-09-30 $1,916,448 1,497,226
2025-06-30 $2,471,514 1,993,158
2025-03-31 $2,695,445 2,284,278
2024-12-31 $2,719,405 1,486,015
2024-09-30 $1,092,841 642,849
2024-06-30 $1,135,912 829,134
2024-03-31 $2,539,697 677,253
2023-12-31 $332,499 33,894
2023-09-30 $189,101 22,647
2023-06-30 $3,060,089 230,082
2023-03-31 $8,674,578 749,100
2023-03-31 $423,526 36,574
2022-12-31 $432,189 52,835
2022-09-30 $465,873 80,185
2022-06-30 $175,169 39,631
2022-03-31 $884,719 97,222
2021-12-31 $2,045,630 99,982
2021-09-30 $2,799,052 109,552
2021-06-30 $5,431,120 155,308
2021-03-31 $2,893,972 86,880
2020-12-31 $2,150,010 82,884
2020-09-30 $373,135 37,805
2020-06-30 $119,508 34,640
2020-03-31 $451,294 147,482